Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)
Kathryn Cecilia Arbour, Salman Rafi Punekar, Ignacio Garrido‐Laguna, David S. Hong, Brian Matthew Wolpin, Meredith S. Pelster and 9 more
- Rank
- 19 of 3,639
- Percentile
- top 0.6%
- Where
- Annals of Oncology, 2023
- Citations
- 129
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.